About
Marco Prunotto brings hands-on bench-to-bedside experience from leading Roche's phenotypic drug discovery, nephrology and translational research teams, while serving as Full Professor and teaching scientists VC evaluation of translational value.
Invests in
BiotechDigital HealthHealthtechMedical Devices
Experience
- MedicxiVenture Partnercurrent2024 — presentGenève, Suisse
- University of GenevaFull Professorcurrent2025 — present
- University of GenevaPrivat Docent (Senior Lecturer) - School of Pharmaceutical Sciences2018 — 2025Geneva Area, Switzerland
- RocheGlobal Head of Technology and Translational Research2021 — 2023Basel, Switzerland
- GalapagosHead of Translational Research2020 — 2021Basel, Basel-Town, Switzerland
- GenentechHead of I2O Innovation Office (Clinical Science Director)2018 — 2020Basel and San Francisco
- GenentechSenior Clinical Development Scientist2016 — 2018
- RochePhenotypic Drug Discovery & Target Identification Lead2013 — 2016Région de Basel, Suisse
- RocheRenal/Fibrosis Group lead (Principal Senior Scientist)2012 — 2013Région de Basel, Suisse
- RocheLaboratory Head (Principal Scientist)2010 — 2012Région de Basel, Suisse
- IRCCS Ospedale Pediatrico Giannina GasliniCell Biologist @ the Nephrology Department2008 — 2010Genoa Area, Italy
- University of GenevaPostdoctoral Fellow - - Pathology & Immunology Dept2004 — 2007Geneva Area, Switzerland
Education
- Università degli Studi di TorinoDoctor of Philosophy (PhD) - College of Veterinary Medicine, Basic Science and Applied Veterinary Biotechnology2000 — 2004
- Università degli Studi di TorinoMaster of Biology (Botany), Biology - Botany1992 — 1998
Skills & more
Artificial Intelligence (AI)2Artificial Neural Networks2Biology1Biochemistry16Biotechnology22Clinical Development12Cell17Drug Discovery49In Vitro36Life Sciences37In vitro8Molecular Biology15
+7 more
OncologyPharmaceutical IndustryPharmacologyCell BiologyCell CultureDrug DevelopmentImmunologyLanguages English · French · German · Italian
From Marco's professional profile.
Same school
Also attended Università degli Studi di Torino40
Andrea Di CamilloFounder, CEO & Managing Partner at P101 VenturesAndrea SilvelloBanking & Real Estate at Proximity CapitalFederico GaliziaIFC Vice President and Chief Risk Officer at International Finance CorporationAlberto CrestoGeneral Partner at Lunar VenturesGiovanni FabaroInvestment Associate at Oltre ImpactEmanuele LeviPartner at 360 Capital
+ 34 more
Shared employers
Also worked at University of Geneva11
Hadrien BouchezPartner at Kurma PartnersVincent OssipowPartner at Omega FundsKris KaczmarekInvestment Director at QDNL ParticipationsBenoit DubuisSwitzerland Board Member at MassChallenge MexicoAshley PilipiszynVenture Partner at Growth Warrior CapitalIvo SarjanovicVenture Partner at GLOCAL Latam
+ 5 more
Also worked at Roche75
Joseph HorsmanInvestor at Madrona Venture GroupMike FitzgeraldInvestor at High AlphaUri LopatinInvestor at Khosla VenturesJan-Olivier FillolsSenior Managing Director at Marlin Equity PartnersNarges BaniasadiVenture Partner at Think+ Ventures Management, LlcAlex MaywegManaging Director at Versant Ventures
+ 69 more
Also worked at Galapagos4
Also worked at Genentech89
David SchenkeinInvestor at GV (Google Ventures)Karthik ArdhanareeswaranInvestor at GV (Google Ventures)Logan HilleLife Sciences Analyst at CincyTechJosephine ChenInvestor at Sequoia CapitalAbbie CelnikerInvestor at Third Rock VenturesMark LevinRetired Founding Partner at Third Rock Ventures
+ 83 more
